Artwork

Inhoud geleverd door Sharon Kedar. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Sharon Kedar of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Player FM - Podcast-app
Ga offline met de app Player FM !

Healthier America: ARPA-H and the Return on Investment for the American People with Dr. Renee Wegrzyn

29:24
 
Delen
 

Manage episode 435183864 series 3532255
Inhoud geleverd door Sharon Kedar. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Sharon Kedar of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

In this episode of Innovate and Elevate, Sharon Kedar is joined by Dr. Renee Wegrzyn, the inaugural director of the Advanced Research Projects Agency for Health (ARPA-H), a government agency designed to drive high-impact health innovations. Appointed by President Biden in 2022, Dr. Wegrzyn shares her deep experience in both synthetic biology and biosecurity, drawing from her work at DARPA, IARPA, and Ginkgo Bioworks.

The conversation dives into the unique role of government in fostering breakthrough technologies, emphasizing ARPA-H’s mission to transform health outcomes. Dr. Wegrzyn explains how ARPA-H takes on ambitious, high-risk projects with the potential to revolutionize healthcare, much like DARPA’s past successes in defense technologies, such as the early development of mRNA technology.

Dr. Wegrzyn highlights ARPA-H’s approach to maximizing the return on investment for American taxpayers by focusing on scalable, impactful solutions that can transition to the private sector. She walks listeners through transformative projects, including NITRO, GLIDE, ADAPT, and POSEIDON.

ARPA-H has a unique Program Management structure, which provides hands-on mentorship and support to ARPA-H grantees. Dr. Wegrzyn identifies how the partnership helps innovators address cost, accessibility, and user experience in health innovations. Sharon and Dr. Wegrzyn also discuss the ARPA-H’s Sprint for Women's Health and how the funding opportunity addresses critical unmet challenges in the women’s health sector.

Episode Outline

(01:50) How the US Government Drives Innovation

(04:01) The Return on Investment to Americans

(09:27) ARPA-H Programs and Funding

(12:42) How To Work with ARPA-H

(15:28) The Audacity to Imagine Success

(18:59) Improving Research and the Standard of Care

(21:40) Women’s Health Innovation

(26:45) Beyond Conversation: Embracing Data-Driven Solutions

Connect with Sharon


Connect with Dr. Renee Wegrzyn


Additional Resources


This podcast is produced by the women at The Wave Editing

  continue reading

12 afleveringen

Artwork
iconDelen
 
Manage episode 435183864 series 3532255
Inhoud geleverd door Sharon Kedar. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Sharon Kedar of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

In this episode of Innovate and Elevate, Sharon Kedar is joined by Dr. Renee Wegrzyn, the inaugural director of the Advanced Research Projects Agency for Health (ARPA-H), a government agency designed to drive high-impact health innovations. Appointed by President Biden in 2022, Dr. Wegrzyn shares her deep experience in both synthetic biology and biosecurity, drawing from her work at DARPA, IARPA, and Ginkgo Bioworks.

The conversation dives into the unique role of government in fostering breakthrough technologies, emphasizing ARPA-H’s mission to transform health outcomes. Dr. Wegrzyn explains how ARPA-H takes on ambitious, high-risk projects with the potential to revolutionize healthcare, much like DARPA’s past successes in defense technologies, such as the early development of mRNA technology.

Dr. Wegrzyn highlights ARPA-H’s approach to maximizing the return on investment for American taxpayers by focusing on scalable, impactful solutions that can transition to the private sector. She walks listeners through transformative projects, including NITRO, GLIDE, ADAPT, and POSEIDON.

ARPA-H has a unique Program Management structure, which provides hands-on mentorship and support to ARPA-H grantees. Dr. Wegrzyn identifies how the partnership helps innovators address cost, accessibility, and user experience in health innovations. Sharon and Dr. Wegrzyn also discuss the ARPA-H’s Sprint for Women's Health and how the funding opportunity addresses critical unmet challenges in the women’s health sector.

Episode Outline

(01:50) How the US Government Drives Innovation

(04:01) The Return on Investment to Americans

(09:27) ARPA-H Programs and Funding

(12:42) How To Work with ARPA-H

(15:28) The Audacity to Imagine Success

(18:59) Improving Research and the Standard of Care

(21:40) Women’s Health Innovation

(26:45) Beyond Conversation: Embracing Data-Driven Solutions

Connect with Sharon


Connect with Dr. Renee Wegrzyn


Additional Resources


This podcast is produced by the women at The Wave Editing

  continue reading

12 afleveringen

Alle afleveringen

×
 
Loading …

Welkom op Player FM!

Player FM scant het web op podcasts van hoge kwaliteit waarvan u nu kunt genieten. Het is de beste podcast-app en werkt op Android, iPhone en internet. Aanmelden om abonnementen op verschillende apparaten te synchroniseren.

 

Korte handleiding